Antitumor potential of plant protein (Riproximin) against breast and colorectal cancer: Facts from functional and molecular investigations
Biomedical Current Insights · 2025
DOI: 10.63626/xk4gxb72 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Current Insights, 2025. Verfasst von Syeda Shafia Ali und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Ribosomal inactivating proteins comprise a big domain and inactivate the ribosomal machinery of the target cells irreversibly and induce toxic effects. Riproximin is a type II ribosomal inactivating protein which has been found lethal against various cancer cells originating from different tissues including breast and colorectal. The purpose of this study was to evaluate the effects of riproximin exposure on cell cycle relevant genes in breast and colorectal cancer cells.
Methods
Toxic effects of riproximin in breast (MDA-MB-231, MCF-7) and colorectal cancer cell lines (SW480, SW620) were identified by MTT assay. AT molecular levels, the cell lines were treated with riproximin separately and expressional levels of the three S-phase cell cycle related genes (MCM3, MCM5, CDC6) were evaluated to identify the concentration effects of riproximin. Untreated samples were used as controls throughout the study.
Results
Riproximin induced toxic effects in breast and colorectal cancer cells (IC50
Zitieren
APA
Ali, S. S., & Akhtar, M. S. (2025). Antitumor potential of plant protein (Riproximin) against breast and colorectal cancer: Facts from functional and molecular investigations. Biomedical Current Insights. https://doi.org/10.63626/xk4gxb72
Vancouver
Ali SS, Akhtar MS. Antitumor potential of plant protein (Riproximin) against breast and colorectal cancer: Facts from functional and molecular investigations. Biomedical Current Insights. 2025. doi:10.63626/xk4gxb72
BibTeX
@article{Ali2025,
author = {Ali, Syeda Shafia and Akhtar, Muhammad Shoaib},
title = {Antitumor potential of plant protein (Riproximin) against breast and colorectal cancer: Facts from functional and molecular investigations},
journal = {Biomedical Current Insights},
year = {2025},
doi = {10.63626/xk4gxb72}
}
EUVIMED